Carey John F 4
4 · TransMedics Group, Inc. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Carey John F
VP of Operations
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-02-01−47→ 13,543 totalExercise: $38.46Exp: 2031-02-24→ Common Stock (47 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-02-01−1,363→ 4,887 totalExercise: $16.14Exp: 2030-02-27→ Common Stock (1,363 underlying) - Exercise/Conversion
Common Stock
2023-02-01$16.14/sh+1,363$21,999→ 15,483 total - Exercise/Conversion
Common Stock
2023-02-01$38.46/sh+47$1,808→ 15,530 total - Sale
Common Stock
2023-02-01$62.52/sh−379$23,695→ 14,569 total - Sale
Common Stock
2023-02-01$64.04/sh−96$6,148→ 14,473 total - Sale
Common Stock
2023-02-01$64.88/sh−139$9,018→ 14,334 total - Sale
Common Stock
2023-02-01$62.00/sh−582$36,084→ 14,948 total - Sale
Common Stock
2023-02-01$65.81/sh−214$14,083→ 14,120 total
Footnotes (8)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F7]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
- [F8]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.